ArticlePloS one2016

Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research.

Hye Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.